Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence
- PMID: 34454872
- DOI: 10.1016/j.sapharm.2021.08.011
Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence
Abstract
Background: Patients are often exposed to contradictory information about pharmaceutical products from various types of advertising. For example, direct-to-consumer advertising (DTCA) tend to emphasize a drug's benefits, while drug injury advertising emphasizes the worst side effects. Regarding DTCA as a drug information source, many researchers in pharmacy field focus on investigating the misinformation in DTCA and corrective advertising. However, no prior research has examined the effects of such contradictory advertising messages on patients' prescription medicine-related beliefs and medication adherence. This is a significant gap in the research literature on pharmaceutical advertising effects and medication adherence.
Objective: This is aimed to examine how exposure to DTCA and drug injury advertising would influence patients' chronic accessibility of drug-related beliefs and their medication adherence behavior.
Methods: An online survey was conducted with a sample of 213 patients taking prescription blood thinners.
Results: The findings from this study did not support the predicted relationship between exposure to DTCA and consumers' drug-related belief accessibility or their medication adherence. However, this study found a significant interaction effect of exposure to DTCA and exposure to drug injury ads on patients' medication adherence. The analysis results demonstrate that, for those who were exposed to drug injury ads, a significant negative relationship emerged between DTCA exposure and medication adherence.
Conclusion: This study provides important empirical evidence of a negative interaction effect of exposure to DTCA and drug injury ads on patients' medication adherence, which demonstrates that the influence of DTCA and drug injury ad exposures on patients' medication adherence is not independent, separate process but an interactive process. A communication campaign with corrective advertising could alleviate the negative interaction effect of exposure to contradictory information from different types of pharmaceutical ads on patients' medication adherence.
Keywords: Conflicting information effects; DTC prescription drug advertising; Drug injury advertising; Medication adherence.
Copyright © 2021. Published by Elsevier Inc.
Similar articles
-
Relationship Between Exposure to Direct-To-Consumer Prescription Drug Advertising (DTCA) and Patients' Belief Accessibility and Medication Adherence.Health Commun. 2019 Aug;34(9):975-983. doi: 10.1080/10410236.2018.1449070. Epub 2018 Mar 9. Health Commun. 2019. PMID: 29521524
-
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.JAMA Health Forum. 2022 Aug 5;3(8):e222570. doi: 10.1001/jamahealthforum.2022.2570. JAMA Health Forum. 2022. PMID: 36200632 Free PMC article. Clinical Trial.
-
Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.J Med Internet Res. 2023 Jul 17;25:e40616. doi: 10.2196/40616. J Med Internet Res. 2023. PMID: 37459159 Free PMC article. Clinical Trial.
-
Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.Health Commun. 2020 May;35(6):739-746. doi: 10.1080/10410236.2019.1584781. Epub 2019 Apr 11. Health Commun. 2020. PMID: 30973021 Free PMC article.
-
Does direct-to-consumer advertising affect patients' choice of pain medications?Curr Pain Headache Rep. 2008 Apr;12(2):89-93. doi: 10.1007/s11916-008-0017-2. Curr Pain Headache Rep. 2008. PMID: 18474186 Review.
Cited by
-
Drug advertising in the German free-of-charge health magazine Apotheken Umschau (Pharmacy review): a critical analysis.Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2145-2157. doi: 10.1007/s00210-023-02744-7. Epub 2023 Oct 4. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37792047 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous